DK0831837T3 - Anvendelse af squalamin i fremstilling af et medikament til inhibering af NHE - Google Patents
Anvendelse af squalamin i fremstilling af et medikament til inhibering af NHEInfo
- Publication number
- DK0831837T3 DK0831837T3 DK96919096T DK96919096T DK0831837T3 DK 0831837 T3 DK0831837 T3 DK 0831837T3 DK 96919096 T DK96919096 T DK 96919096T DK 96919096 T DK96919096 T DK 96919096T DK 0831837 T3 DK0831837 T3 DK 0831837T3
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- inhibitors
- nhe
- squalamine
- medicament
- Prior art date
Links
- UIRKNQLZZXALBI-MSVGPLKSSA-N Squalamine Chemical compound C([C@@H]1C[C@H]2O)[C@@H](NCCCNCCCCN)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@H](C(C)C)OS(O)(=O)=O)[C@@]2(C)CC1 UIRKNQLZZXALBI-MSVGPLKSSA-N 0.000 title 1
- UIRKNQLZZXALBI-UHFFFAOYSA-N Squalamine Natural products OC1CC2CC(NCCCNCCCCN)CCC2(C)C2C1C1CCC(C(C)CCC(C(C)C)OS(O)(=O)=O)C1(C)CC2 UIRKNQLZZXALBI-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229950001248 squalamine Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 239000003112 inhibitor Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 238000001228 spectrum Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/474,799 US5792635A (en) | 1995-06-07 | 1995-06-07 | Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine |
PCT/US1996/008954 WO1996040151A1 (en) | 1995-06-07 | 1996-06-07 | Use of squalamine for the manufacture of a medicament for inhibiting nhe |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0831837T3 true DK0831837T3 (da) | 2003-08-25 |
Family
ID=23884982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96919096T DK0831837T3 (da) | 1995-06-07 | 1996-06-07 | Anvendelse af squalamin i fremstilling af et medikament til inhibering af NHE |
Country Status (12)
Country | Link |
---|---|
US (1) | US5792635A (pt) |
EP (1) | EP0831837B1 (pt) |
JP (1) | JP4077512B2 (pt) |
AT (1) | ATE238800T1 (pt) |
AU (1) | AU712436B2 (pt) |
CA (1) | CA2223908C (pt) |
DE (1) | DE69627853T2 (pt) |
DK (1) | DK0831837T3 (pt) |
ES (1) | ES2201187T3 (pt) |
PT (1) | PT831837E (pt) |
WO (1) | WO1996040151A1 (pt) |
ZA (1) | ZA964819B (pt) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5856535A (en) * | 1994-08-18 | 1999-01-05 | Magainin Pharmaceuticals, Inc. | Aminosterol ester compounds |
ATE249797T1 (de) | 1995-06-07 | 2003-10-15 | Conceptus Inc | Transcervikale verhütungsvorrichtung zum eileiterverschliessen mit mechanischer befestigung am eileiter |
US5847172A (en) * | 1995-06-07 | 1998-12-08 | Magainin Pharmaceuticals Inc. | Certain aminosterol compounds and pharmaceutical compositions including these compounds |
US6143738A (en) * | 1995-06-07 | 2000-11-07 | Magainin Pharmaceuticals, Inc. | Therapeutic uses for an aminosterol compound |
CA2252584C (en) * | 1996-04-26 | 2008-06-10 | Magainin Pharmaceuticals Inc. | Treatment of carcinomas using squalamine in combination with other anti-cancer agents |
US6596712B2 (en) | 1996-04-26 | 2003-07-22 | Genaera Corporation | Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities |
US7410959B1 (en) * | 2000-07-13 | 2008-08-12 | Genaera Corporation | Therapeutic uses for aminosterol compounds |
EP0923377A1 (en) * | 1996-05-17 | 1999-06-23 | Magainin Pharmaceuticals Inc. | Therapeutic uses for an aminosterol compound |
WO1998019682A1 (en) * | 1996-11-01 | 1998-05-14 | Magainin Pharmaceuticals Inc. | Certain aminosterol compounds and uses therefor |
US6262283B1 (en) | 1996-12-06 | 2001-07-17 | Magainin Pharmaceuticals Inc. | Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds |
GB9923076D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
ID26989A (id) * | 1998-03-26 | 2001-02-22 | Phytopharm Plc | Smilagenin dan anzurogenin-d untuk pengobatan penyakit alzheimer |
DE19849722A1 (de) * | 1998-10-28 | 2000-05-04 | Aventis Pharma Gmbh | Substituierte Phenyl-alkenoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
GB9923078D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
GB9923077D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
US7074778B2 (en) | 1999-12-09 | 2006-07-11 | Genaera Corporation | Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
DE19960204A1 (de) * | 1999-12-14 | 2001-06-28 | Aventis Pharma Gmbh | Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
EP1274718B1 (en) | 2000-04-12 | 2006-10-18 | Genaera Corporation | A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group |
GB0107822D0 (en) * | 2001-03-28 | 2001-05-23 | Phytopharm Plc | Sapogenin derivatives their synthesis and use methods based upon their use |
US20050130948A1 (en) * | 2002-03-27 | 2005-06-16 | Daryl Rees | Therapeutic methods and uses of sapogenins and their derivatives |
KR101130212B1 (ko) * | 2002-03-27 | 2012-04-13 | 파이토팜 피엘씨 | 사포게닌 및 그 유도체의 치료 방법 및 사용법 |
EP2527355B1 (en) | 2005-04-25 | 2019-02-20 | Enterin, Inc. | Polymorphic and amorphous salt forms of squalamine dilactate |
US20080058300A1 (en) * | 2006-04-21 | 2008-03-06 | Mclane Michael | Induction of weight loss and the selective inhibition of PTP1B |
CA2985271A1 (en) * | 2007-09-06 | 2009-03-12 | Ohr Pharmaceutical, Inc. | A method for treating diabetes |
US20120088737A2 (en) * | 2009-10-02 | 2012-04-12 | Ajinomoto Co., Inc | Novel acyl guanidine derivatives |
WO2011056650A2 (en) | 2009-10-27 | 2011-05-12 | Michael Zasloff | Methods and compositions for treating and preventing viral infections |
WO2011066260A2 (en) * | 2009-11-25 | 2011-06-03 | Michael Zasloff | Formulations comprising aminosterols |
TR201911039T4 (tr) * | 2012-04-20 | 2019-08-21 | Ohr Pharmaceutical Inc | Ptp1b ile ilişkili bir hastalığın tedavisine yönelik aminosteroidler. |
DK3461834T3 (da) * | 2013-03-13 | 2021-08-23 | Sage Therapeutics Inc | Neuroaktive steroider |
US10040817B2 (en) | 2013-10-03 | 2018-08-07 | Enterin Laboratories, Inc. | Methods and compositions for stimulation of the intestinal enteroendocrine system for treating diseases or conditions related to the same |
CN113501855A (zh) | 2015-07-06 | 2021-10-15 | 萨奇治疗股份有限公司 | 氧甾醇及其使用方法 |
DK3436022T3 (da) | 2016-04-01 | 2022-06-20 | Sage Therapeutics Inc | Oxysteroler og fremgangsmåder til anvendelse heraf |
WO2017193046A1 (en) | 2016-05-06 | 2017-11-09 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
CA3038900A1 (en) | 2016-09-30 | 2018-04-05 | Sage Therapeutics, Inc. | C7 substituted oxysterols and methods as nmda modulators |
CN114478677A (zh) | 2016-10-18 | 2022-05-13 | 萨奇治疗股份有限公司 | 氧甾醇及其使用方法 |
WO2019050903A1 (en) | 2017-09-08 | 2019-03-14 | Enterin Laboratories, Inc. | METHODS OF TREATING SLEEP DISORDERS, SLEEP DISTURBANCES AND ASSOCIATED SYMPTOMS USING AMINOSTEROL COMPOSITIONS |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3016390A (en) * | 1960-06-30 | 1962-01-09 | Searle & Co | N-(substituted alkyl) amino-5alpha-androstan-17beta-ols |
US3370070A (en) * | 1965-06-16 | 1968-02-20 | Searle & Co | [n-alkyl-17-(dialkylaminoalkyl)amino] androst-4-en-3-ones |
GB1565351A (en) * | 1975-06-02 | 1980-04-16 | Theramex | Steroid aminoethers |
US4220598A (en) * | 1977-11-14 | 1980-09-02 | Abbott Laboratories | Method and reagents for measuring the level of conjugated bile acids |
US4550163A (en) * | 1979-02-05 | 1985-10-29 | Abbott Laboratories | Ligand analog-irreversible enzyme inhibitor conjugates |
US4372888A (en) * | 1980-08-26 | 1983-02-08 | The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | Nondenaturing zwitterionic detergents |
JPS5842878B2 (ja) * | 1981-12-02 | 1983-09-22 | 名糖産業株式会社 | 12−オキソコラン酸トシルヒドラゾン化合物、その製法ならびに利用 |
EP0101554B1 (en) * | 1982-07-29 | 1986-10-15 | Lehner A.G. | New derivatives of biliary acids, process for the production thereof and pharmaceutical compositions containing the same |
US4994443A (en) * | 1982-12-20 | 1991-02-19 | The Children's Medical Center Corporation | Inhibition of angiogenesis |
US5001116A (en) * | 1982-12-20 | 1991-03-19 | The Children's Medical Center Corporation | Inhibition of angiogenesis |
IT1221734B (it) * | 1983-02-24 | 1990-07-12 | Schiena Michele Giuseppe Di | Ursodesossicolico solfato acido sale sodico |
US4545938A (en) * | 1983-11-02 | 1985-10-08 | Beth Israel Medical Center | Chemical synthesis |
EP0243449A1 (en) * | 1985-10-18 | 1987-11-04 | The Upjohn Company | Cyclic hydrocarbons with an aminoalkyl sidechain |
US4771042A (en) * | 1985-11-25 | 1988-09-13 | The Upjohn Company | Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments |
JPS62175497A (ja) * | 1986-01-28 | 1987-08-01 | Wakunaga Pharmaceut Co Ltd | 胆汁酸誘導体およびその製造法 |
US5075464A (en) * | 1987-04-22 | 1991-12-24 | Merrell Dow Pharmaceuticals Inc. | 17β-(cyclopropylamino)androstene derivatives |
SE8702254D0 (sv) * | 1987-05-29 | 1987-05-29 | Kabivitrum Ab | Novel heparin derivatives |
US5135919A (en) * | 1988-01-19 | 1992-08-04 | Children's Medical Center Corporation | Method and a pharmaceutical composition for the inhibition of angiogenesis |
IT1229570B (it) * | 1989-04-17 | 1991-09-04 | Giuliani Spa | Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono. |
IT1229569B (it) * | 1989-04-17 | 1991-09-04 | Giuliani Spa | Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono. |
JPH07116215B2 (ja) * | 1989-04-19 | 1995-12-13 | エスエス製薬株式会社 | 新規なステロイド化合物 |
PT93847A (pt) * | 1989-04-24 | 1990-11-20 | Harvard College | Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem |
US4966897A (en) * | 1989-08-15 | 1990-10-30 | Merrell Dow Pharmaceuticals Inc. | 4-substituted 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors |
US5004737A (en) * | 1989-09-22 | 1991-04-02 | Pacific Chemical Co., Ltd. | Quaternary ammonium-substituted sterol derivatives |
EP0466315A3 (en) * | 1990-05-30 | 1992-07-01 | Larrian Gillespie | Compositions containing xylan sulphates for affecting growth factor function and for inhibiting fibroblast proliferation |
WO1991019731A1 (en) * | 1990-06-11 | 1991-12-26 | The Upjohn Company | Steroids which inhibit angiogenesis |
EP0489423B1 (de) * | 1990-12-06 | 1996-11-06 | Hoechst Aktiengesellschaft | Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindung als Arzneimittel |
US5192756A (en) * | 1992-03-18 | 1993-03-09 | The Children's Hospital Of Pennsylvania | Aminosterol antibiotic |
WO1993025197A1 (en) * | 1992-06-12 | 1993-12-23 | Affymax Technologies N.V. | Compositions and methods for enhanced drug delivery |
AU6392894A (en) * | 1993-02-26 | 1994-09-14 | Magainin Pharmaceuticals, Inc. | Chemical synthesis of squalamine |
CA2157594A1 (en) * | 1993-03-10 | 1994-09-15 | Leah L. Frye | Steroid derivatives, pharmaceutical compositions containing them, and their use as antibiotics or disinfectants |
JPH09509959A (ja) * | 1994-03-10 | 1997-10-07 | マガイニン ファーマシューティカルズ インク. | ステロイド誘導体、それらを含む薬剤組成物、及びそれらの薬剤学的用途 |
CA2223910C (en) * | 1995-06-07 | 2008-09-16 | Magainin Pharmaceuticals Inc. | Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds |
-
1995
- 1995-06-07 US US08/474,799 patent/US5792635A/en not_active Expired - Fee Related
-
1996
- 1996-06-07 EP EP96919096A patent/EP0831837B1/en not_active Expired - Lifetime
- 1996-06-07 WO PCT/US1996/008954 patent/WO1996040151A1/en active IP Right Grant
- 1996-06-07 DE DE69627853T patent/DE69627853T2/de not_active Expired - Fee Related
- 1996-06-07 PT PT96919096T patent/PT831837E/pt unknown
- 1996-06-07 ZA ZA9604819A patent/ZA964819B/xx unknown
- 1996-06-07 ES ES96919096T patent/ES2201187T3/es not_active Expired - Lifetime
- 1996-06-07 JP JP50139797A patent/JP4077512B2/ja not_active Expired - Fee Related
- 1996-06-07 AU AU61528/96A patent/AU712436B2/en not_active Ceased
- 1996-06-07 CA CA002223908A patent/CA2223908C/en not_active Expired - Lifetime
- 1996-06-07 DK DK96919096T patent/DK0831837T3/da active
- 1996-06-07 AT AT96919096T patent/ATE238800T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ZA964819B (en) | 1998-02-09 |
EP0831837A1 (en) | 1998-04-01 |
JP4077512B2 (ja) | 2008-04-16 |
EP0831837B1 (en) | 2003-05-02 |
PT831837E (pt) | 2003-09-30 |
US5792635A (en) | 1998-08-11 |
AU712436B2 (en) | 1999-11-04 |
ATE238800T1 (de) | 2003-05-15 |
JPH11506775A (ja) | 1999-06-15 |
DE69627853T2 (de) | 2004-02-19 |
DE69627853D1 (de) | 2003-06-05 |
CA2223908C (en) | 2007-02-20 |
ES2201187T3 (es) | 2004-03-16 |
WO1996040151A1 (en) | 1996-12-19 |
CA2223908A1 (en) | 1996-12-19 |
AU6152896A (en) | 1996-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0831837T3 (da) | Anvendelse af squalamin i fremstilling af et medikament til inhibering af NHE | |
WO1996040728A3 (en) | Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds | |
TR200001603T2 (tr) | Yeni bileşikler | |
AR010062A1 (es) | Nuevos benzamidaldehidos y su utilizacion | |
DK550188D0 (da) | Antigestagen- og antioestrogenvirksomme forbindelser til behandling af hormonafhaengige tumorer | |
TR200102800T2 (tr) | Yeni bileşikler. | |
SE9504661D0 (sv) | New compounds | |
ES2193252T3 (es) | Quinolonas y su uso terapeutico. | |
DE69926806D1 (de) | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren | |
DK125796A (da) | I form af små molekyler foreliggende inhibitorer for rotamaseaktivitet | |
ES2189235T3 (es) | 6-fenilfenantridinas sustituidas. | |
TR199801255T2 (xx) | Vitronektin resept�r antagonistleri. | |
ATE228111T1 (de) | M-amidinophenyl-analoga als faktor-xa-inhibitoren | |
BR9707233A (pt) | Fenantridinas | |
DK0767798T3 (da) | Sterolderivater anvendt til regulering af meiose | |
TR199901653T2 (xx) | Fitalazinonlar. | |
DE69926919D1 (de) | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren | |
TR200100075T2 (tr) | 2-Kuinolon ihtiva eden farmasötik bileşimler | |
DE69523622D1 (de) | Diastereomerenreine 3-oxo und 3-thioxo-4-aza-androstanderivate und ihre verwendung als antiandrogene | |
TR200003377T2 (tr) | Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol | |
NO975557D0 (no) | Immortalisering og dismortalisering av celler | |
CO5040088A1 (es) | Nuevos compuestos y usos anestesicos locales | |
DK0639275T3 (da) | Hidtil ukendte GABAa-receptorundertyper og fremgangsmåder til screening af lægemiddelforbindelser under anvendelse af imidazoquinoxaliner og pyrrolopyimidiner til binding til GABAa-receptorundertyper | |
SE9504662D0 (sv) | New compounds | |
TR200100133T2 (tr) | FKBP İnhibitörleri |